On Tuesday, JFrog earned an upgrade to its Relative Strength (RS) Rating, from 78 to 82.
IBD's proprietary rating identifies share price performance with a 1 (worst) to 99 (best) score. The score shows how a stock's price performance over the trailing 52 weeks stacks up against all the other stocks in our database.
Decades of market research reveals that the best stocks typically have an RS Rating of above 80 in the early stages of their moves.
Risk Management In The Stock Market: How Much Money To Invest Now
JFrog is not currently offering a proper buying opportunity. See if the stock goes on to form a promising consolidation that could spark a new run.
Earnings growth fell in the company's most recent report from 36% to 0%, but the top line rose from 22% to 23%. Look for the next report on or around Feb. 13.
JFrog earns the No. 51 rank among its peers in the Computer Software-Enterprise industry group. Enfusion, Samsara and Klaviyo are among the top 5 highly rated stocks within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
